Covid-19 roundup: Fauci reiterates October vaccine OK 'unlikely'; Pfizer and BioNTech reserve 200M doses for EU
Anthony Fauci is doubling down on the message that a vaccine authorization by November 3 is “unlikely,” even if not impossible, joining a growing chorus of government officials who are going against ultra-optimistic timelines from certain developers.
Echoing Moncef Slaoui — the scientific chief of Operation Warp Speed — who sees a low chance of the ongoing Phase III trials reading out before the end of October, Fauci told Judy Woodruff on PBS NewsHour that data that can offer a definitive answer on the leading vaccines’ safety and efficacy are more likely to arrive “by the end of the year.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,500+ biopharma pros reading Endpoints daily — and it's free.